List of insiders holdings for MOMENTA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | NOVARTIS AG 10% Owner |
2016-08-30 17:05:20 | 3,315,366 0 |
3,315,366 | Form 13D |
| 2 | POLARIS VENTURE MANAGEMENT CO III LLC POLARIS VENTURE PARTNERS III LP POLARIS VENTURE PARTNERS FOUNDERS FUND III LP POLARIS VENTURE PARTNERS ENTREPRENEURS FUND III LP Arnold Stephen D Flint Jonathan A MCGUIRE TERRANCE SPOON ALAN G 10% Owner |
2006-02-14 11:28:29 | 1,816,749 0 |
1,816,749 | Form 13G |
| 3 | MVM International Life Sciences Fund No 1 L P 10% Owner |
2007-01-31 15:34:04 | 1,369,696 0 |
1,369,696 | Form 13G |
| 4 | Reeders Stephen T Director |
2008-03-31 20:07:17 | 5,429 947,576 |
953,005 | Form 4 |
| 5 | LANGER ROBERT Director |
2008-08-11 16:59:08 | 950,022 0 |
950,022 | Form 4 |
| 6 | Crane Alan L Former Director Director |
2010-05-24 17:40:58 | 741,720 0 |
741,720 | Form 4/A |
| 7 | Brugger Stephen B Chief Operating Officer |
2010-11-01 17:57:13 | 674,376 0 |
674,376 | Form 4 |
| 8 | Kaundinya Ganesh Venkataraman COO & CSO |
2018-08-23 16:22:06 | 495,145 0 |
495,145 | Form 4 |
| 9 | Sasisekharan Ram Director |
2010-07-27 16:50:11 | 340,274 0 |
340,274 | Form 4 |
| 10 | ZABRISKIE JOHN L Director |
2004-07-01 21:33:30 | 251,998 0 |
251,998 | Form 4 |
| 11 | HUTT PETER BARTON Director |
2014-09-15 15:25:33 | 203,725 0 |
203,725 | Form 4 |
| 12 | CLARKE JOHN K Director |
2015-06-11 11:55:08 | 176,350 0 |
176,350 | Form 4 |
| 13 | Leicher Bruce SVP & General Counsel |
2018-08-23 16:21:32 | 171,801 0 |
171,801 | Form 4 |
| 14 | TYLER JOSEPH E Vice President, Manufacturing |
2004-07-13 15:30:59 | 163,200 0 |
163,200 | Form 3 |
| 15 | Bishop John E Senior VP, Pharmaceutical Scie |
2016-05-23 12:40:04 | 157,253 0 |
157,253 | Form 4 |
| 16 | Roach James M. Senior VP, Development and Chi |
2016-11-23 10:41:14 | 155,381 0 |
155,381 | Form 4 |
| 17 | Shea Richard P SVP, CFO |
2016-12-16 15:41:04 | 119,906 0 |
119,906 | Form 4 |
| 18 | Storer Scott M SVP, CFO |
2018-02-14 18:15:12 | 99,783 0 |
99,783 | Form 4 |
| 19 | Barrett Peter Director |
2008-06-09 16:25:45 | 96,000 0 |
96,000 | Form 4 |
| 20 | SULAT JAMES R Director |
2019-06-21 16:14:04 | 79,090 0 |
79,090 | Form 4 |
| 21 | Ottmer Matthew P. Chief Operating Officer |
2017-02-09 16:52:30 | 72,000 0 |
72,000 | Form 4 |
| 22 | Whoriskey Susan K V.P., Lic. & Bus. Dev. |
2007-05-25 16:16:47 | 65,500 0 |
65,500 | Form 4 |
| 23 | Lisa Carron Shmerling V.P., Legal Affairs |
2007-03-22 16:52:51 | 63,250 0 |
63,250 | Form 4 |
| 24 | Westphal Christoph H Director |
2005-05-27 13:31:58 | 57,600 0 |
57,600 | Form 4 |
| 25 | Koestler Thomas P Director |
2019-06-21 16:14:47 | 40,590 0 |
40,590 | Form 4 |
| 26 | Franken Michael President, Biosimilars Busines |
2015-12-14 11:16:08 | 37,968 0 |
37,968 | Form 4 |
| 27 | Fishman Corey N. Director |
2019-06-21 16:16:28 | 35,090 0 |
35,090 | Form 4 |
| 28 | GOLDENHEIM PAUL D Director |
2006-05-31 18:07:11 | 34,562 0 |
34,562 | Form 4 |
| 29 | Fanucci Marsha Director |
2016-06-27 14:31:28 | 25,500 0 |
25,500 | Form 4 |
| 30 | Shapiro Bennett M Director |
2016-06-08 15:55:37 | 24,834 0 |
24,834 | Form 4 |
| 31 | ROBERTSON MICHELLE Chief Financial Officer |
2019-10-29 20:57:54 | 6,813 0 |
6,813 | Form 4 |
| 32 | KWON YOUNG Chief Financial & Bus. Officer |
2020-10-01 17:05:24 | 0 0 |
0 | Form 4 |
| 33 | Stoner Elizabeth Director |
2020-10-01 17:18:25 | 0 0 |
0 | Form 4 |
| 34 | Gutierrez-Ramos Jose-Carlos Director |
2020-10-01 17:17:07 | 0 0 |
0 | Form 4 |
| 35 | GROGAN DONNA ROY Director |
2020-10-01 17:15:51 | 0 0 |
0 | Form 4 |
| 36 | GILMAN STEVEN C Director |
2020-10-01 17:14:42 | 0 0 |
0 | Form 4 |
| 37 | GEMAYEL GEORGES Director |
2020-10-01 17:12:58 | 0 0 |
0 | Form 4 |
| 38 | DOWNEY BRUCE Director |
2020-10-01 17:10:44 | 0 0 |
0 | Form 4 |
| 39 | Barlow Jane F Director |
2020-10-01 17:08:34 | 0 0 |
0 | Form 4 |
| 40 | Manning Anthony M. Chief Scientific Officer |
2020-10-01 17:07:30 | 0 0 |
0 | Form 4 |
| 41 | ATLAS VENTURE FUND V LP ATLAS VENTURE PARALLEL FUND V-A C V ATLAS VENTURE PARALLEL FUND V-B C V ATLAS VENTURE ENTREPRENEURS FUND V LP ATLAS VENTURE FUND VI LP Atlas Venture Fund VI GmbH & Co KG ATLAS VENTURE ENTREPRENEURS FUND VI LP ATLAS VENTURE ASSOCIATES V LP Atlas Venture Associates VI L.P. 10% Owner |
2009-02-13 14:32:46 | 0 0 |
0 | Form 13G |
| 42 | FIER IAN Chief Mfg and Program Officer |
2020-10-01 17:03:22 | 0 0 |
0 | Form 4 |
| 43 | Cieplinska Agnieszka Chief Accounting Officer (PAO) |
2020-10-01 17:01:45 | 0 0 |
0 | Form 4 |
| 44 | Carvajal Alejandra Chief Legal Officer |
2020-10-01 17:00:06 | 0 0 |
0 | Form 4 |
| 45 | BELTRAMELLO JO ANN Chief HR and Inf. Officer |
2020-10-01 16:58:04 | 0 0 |
0 | Form 4 |
| 46 | Arroyo Santiago SVP, Chief Medical Officer |
2020-10-01 16:56:35 | 0 0 |
0 | Form 4 |
| 47 | WHEELER CRAIG A President & CEO |
2020-10-01 16:55:17 | 0 0 |
0 | Form 4 |
| 48 | ATLAS VENTURE FUND V LP ATLAS VENTURE ENTREPRENEURS FUND V LP ATLAS VENTURE ENTREPRENEURS FUND VI LP Atlas Venture Fund VI GmbH & Co KG ATLAS VENTURE FUND VI LP ATLAS VENTURE PARALLEL FUND V-A C V ATLAS VENTURE PARALLEL FUND V-B C V ATLAS VENTURE ASSOCIATES V LP Atlas Venture Associates VI Inc 10% Owner |
2009-02-13 14:32:46 | 0 0 |
0 | Form 13G |